Conference
MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study
Authors
Fox R; Oh J; Arnold D; Syed S; Xu Z; Turner T; Traboulsee A; Reich D
Volume
30
Pagination
pp. 526-527
Publisher
WILEY
Publication Date
June 1, 2023
Conference proceedings
EUROPEAN JOURNAL OF NEUROLOGY
ISSN
1351-5101